News
Syngenta group present at the Enterprise Roadshow
26 April 2024
Our latest Enterprise Roadshow with Syngenta engaged academics interested in Agri Tech including plant biology, chemistry, microbiology and AI. Followup meetings with Syngenta are available.
- Syngenta group present at the Enterprise Roadshow 26 April 2024 Our latest Enterprise Roadshow with Syngenta engaged academics interested in Agri Tech including plant biology, chemistry, microbiology and AI. Followup meetings with Syngenta are available.
- The Enterprise Roadshow: Syngenta 25 March 2024 The Enterprise Roadshow is delighted to welcome Syngenta to the University of Bristol who will present their new Open Innovation programme “Shoots by Syngenta”.
- Supporting researchers in arts, law and social sciences 21 March 2024 The Commercialisation team hosted ESRC/AHRC SHAPE Catalyst as part of our Enterprise Roadshow series.
- The Enterprise Roadshow: Commercialising in quantum tech 21 February 2024 Join us at the Quantum Tech Enterprise Roadshow where the future unfolds in qubits and superposition. Come and meet STL Tech and Delta.g companies which have experience commercialising quantum hardware technologies.
- Opportunities for researchers from arts, law and social sciences at our upcoming Enterprise Roadshow 21 February 2024 Join Prof. Michele Barbour and ESRC/AHRC SHAPE Catalyst’s team to learn about training, funding opportunities and how you can deliver impact-at-scale.
- Forefront RF’s patented tunable duplexer technology now officially trademarked 8 January 2024 RF frequency agnostic solution set to simplify software-defined radio systems in smartphones, wearables and IoT devices.
- Meet Parkwalk, the UK's leading investor in university spin outs 3 January 2024 Find out what investors look for and how to raise funding from Parkwalk Investment Directors Alun Williams and Cassie Doherty.
- Partnering with Start Codon at the Enterprise Roadshow 5 December 2023 Start Codon invest in and support early stage health and life sciences ventures and we heard from Investment Director Michael Salako about role of venture builders in bridging the valley of death when commercializing academic research, and their role in attracting further investment to bring new technology to market.